ResearchThe association between glucagon-like peptide 1 receptor agonists therapy and outcomes after heart transplant
ResearchTicagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis
ResearchCommentary: HALP score and coronary bifurcation percutaneous coronary interventions: a promising prognostic tool
ResearchReevaluating Lipoprotein(a) Levels and Risk of All-Cause Mortality in the Setting of Primary Prevention: A Retrospective Cohort Study
ResearchHigh lipoprotein(a) attenuates the mortality benefit of elevated high-density lipoprotein cholesterol with sex-specific variation: a retrospective cohort study
ResearchGLP-1 Receptor Agonists and Clinical Outcomes in Patients with Type 2 Diabetes Undergoing Transcatheter Aortic Valve Implantation
ResearchRIVAWAR Trial Commentary: Rivaroxaban vs Warfarin in Acute Left Ventricular Thrombus Following Myocardial Infarction
ResearchPercutaneous micro-axial flow pump use during non-emergent high-risk PCI: Systematic review and meta-analysis
ResearchResponse to Letter Regarding "Sodium-Glucose Cotransporter-2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation"
ResearchEarly glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes
ResearchPolymorphic Ventricular Tachycardia After Cardioversion for AF with Tachycardia-induced Cardiomyopathy
Dec 11, 2025Journal ArticleGlucagon-Like Peptide-1 Receptor Agonists Versus Bariatric Surgery in Patients With Obesity and Heart Failure With Preserved Ejection Fraction.Written by 1 Roon author & 14 others Via The American Heart Association Journals